GlassScriptPhysician profile
Paul R Long
NPI 1972820355
$62,419.08
in general payments reported to CMS, 2019-2025
27 companies · $4,343 in 2025
The $4,343 reported for 2025 was more than what 83% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $7,110 · 2021: $24K · 2022: $11K · 2023: $2,062 · 2024: $1,970 · 2025: $4,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,813 · Travel and Lodging: $1,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,813.36 |
| Travel and Lodging | $1,560.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $47,626.92 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Angiodynamics, INC. | $3,241.17 | 2020-2021 | |
| Boston Scientific Corporation | $3,046.40 | 2020-2025 | Enroute Transcarotid Stent, Ranger, Jetstream Sc |
| Penumbra, INC. | $2,918.94 | 2020-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $1,130.38 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cook Medical LLC | $908.07 | 2020-2025 | Cook, Tornado |
| Medtronic Vascular, INC. | $859.55 | 2019-2020 | |
| Endologix LLC | $745.37 | 2020-2021 | |
| Medtronic, INC. | $417.71 | 2021-2025 | Venaseal, Symplicity G3 |
| Janssen Pharmaceuticals, INC | $404.66 | 2020-2022 | |
| Shockwave Medical, INC | $199.14 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cagent Vascular INC | $158.33 | 2023 | Serrantor |
| Shape Memory Medical INC. | $150.00 | 2025 | Impede Embolization Plug |
| Bard Peripheral Vascular, INC. | $123.00 | 2025 | Rotarexs 6 F X 135 Cm |
| Bolton Medical INC | $84.45 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $65.16 | 2022 | |
| Becton, Dickinson and Company | $58.50 | 2024 | Rotarexs 6 F X 135 Cm |
| Inari Medical, INC. | $58.19 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Reflow Medical INC | $37.29 | 2025 | |
| Asahi Intecc USA, INC. | $35.72 | 2025 | Asahi Peripheral Vascular Wires |
| Nevro Corp. | $26.48 | 2024 | Senza |
| Biowound Solutions, INC. | $25.47 | 2025 | Bio-Connekt |
| Abbott Laboratories | $24.00 | 2022 | |
| Acera Surgical, INC. | $22.88 | 2025 | Restrata Wound Matrix |
| Teleflex LLC | $19.00 | 2021 | |
| Lemaitre Vascular, INC. | $17.30 | 2022 | |
| Surmodics, INC. | $15.00 | 2025 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.